Detailed description of the household intervention delivered to Arms A and B, ART delivery during the study period and Arm C activities
The (PopART) CHiPs intervention
The PopART HIV combination prevention package included annual rounds of household visits by Community HIV-care Providers (CHiPs) in the Arm A and Arm B communities, attempting to reach every household in every community at least once per round for the duration of the trial (November 2013-December 2017). At each "annual round" household visit, a team of two CHiPs staff approached a household, requested verbal consent to enter and explain the intervention being offered, and then, with permission, provided HIV education and prevention information, offered HIV rapid testing, offered referral of HIV-positive (HIV+) individuals to the local government healthcare facilities for HIV care/ART, offered referral to medical male circumcision services for HIV-negative men, offered referral to antenatal care for HIV+pregnant women, offered referral for reproductive health and family planning services, provided tuberculosis symptom screening followed by collection of sputum samples and referral to the health facility for those diagnosed with TB, offered sexuallytransmitted-infection symptom screening followed by referral of those with symptoms to the health facility for diagnosis, and provided condoms. Following the initial household visit in an annual round, CHiPs would return to a household during the round to offer the intervention to those not available at a prior visit, to encourage linkage to care for those previously referred for HIV services, and to support retention for those on ART.
Before the start of the PopART intervention, each of the intervention communities was divided into "zones" with on average ~500 households in each zone. Each pair of CHiPs was responsible for providing the intervention to all households in one zone. In the first "annual round" (November CHiPs was on individuals in the age ranges described above, the intervention was offered to all household members irrespective of age, and HIV testing for children was offered with parental or guardian consent, in accordance with national guidelines for age of consent for HIV testing.
During Round 2, and continued in Round 3, additional strategies were implemented to try to increase the percentage of men who were contacted by the CHiPs, and to facilitate more rapid linkage to HIV care among HIV-positive individuals. Depending on the community, these strategies sometimes included focused, short-term campaigns ("zonal campaigns") in a particular CHiP zone, or conduct of HIV testing drives at venues outside the household setting, such as taxi ranks or markets.
Having CHiPs work shifts early or late in the day and on weekends was an effective strategy. To increase the reach to men and youth, male health fairs ("Man-Up" campaigns) and work place testing and HIV awareness campaigns were delivered. To encourage youth to link to care and access prevention materials and condoms, special youth-friendly corners were created in healthcare facilities. There was a greater focus on linkage to care generally in Rounds 2 and 3 compared with 
Arm C activities
In the seven Arm C communities, the study provided no community-based HIV testing. In some Arm C communities, there were times when other organizations or programs did provide mobile HIV testing campaigns, so some non-facility based HIV testing did take place during the study period. In all Arm C communities, any individual wishing to test for HIV could do so through routine government HIV testing services, with ART initiation according to national guidelines. In preparation for the study, additional training focused on HIV care and treatment was provided to the staff at all
Arm C clinics to ensure that the care provided during the study period met national standards. Drug stores were supplemented to ensure no drug-stock outs occurred during the trial period. 
Identification of incident HIV infections
In HPTN 071 (PopART), HIV incidence was determined based on laboratory testing of samples collected from participants in the Population Cohort (PC). Details of the procedures used for HIV testing and the results of that testing will be presented elsewhere. A brief summary is provided below.
HIV status was determined for all PC participants at all study visits, using samples collected during household visits. Centralized laboratories in Zambia and South Africa performed a single HIV screening assay. Additional HIV testing was performed at the HPTN Laboratory Center (LC) using pre- 
Imputation methods
Imputation methods were used in the estimation of primary effectiveness for HIV incidence.
Imputation was used for participants who had eligible follow-up for the primary effectiveness period (PC12-PC36) but missed a visit or did not have an HIV status available at PC12 or PC24. For participants who were HIV-negative following a missed visit, HIV status was imputed as HIV-negative at the missed visit. For participants with missed visits who seroconverted (e.g. were HIV-negative at PC0, missed PC12 and were HIV-positive at PC24), hot deck imputation (a form of bootstrap) was used to impute HIV status at the missed visit. For each seroconverter, HIV status at the missed visit was sampled at random from the pool of seroconverters over the same time period, matching gender and community. The timing of the visit was imputed using mean imputation for each community: the visit date was estimated between observed visits, using the mean proportional timing of follow-up for participants with completed visits. Table S1 shows the number of PC participants and seroconverters with missing information on timing of HIV infection because of missing visits at PC12 and/or PC24. Approximately 50% of the person years in PC0-PC24; 67% of the person years in PC0-PC36 and 100% of the person years in PC12-36 were included in the primary analysis using imputation.
Twenty imputation datasets were created, and the primary analysis results computed for each imputation dataset. The primary endpoint estimate was the mean of the 20 imputation estimates and 95% confidence intervals were constructed using standard imputation methods. 90 targets, and ART coverage, have been described previously 8, 9 , and are summarized here.
Among individuals who participated in the third and last "annual round" of intervention, we estimated the number of HIV-positive individuals as the number who were "known HIV-positive" to the CHiPs (because they self-reported they were HIV-positive, or tested HIV-positive) plus an estimated number among those whose HIV status was not known to CHiPs (because they did not self-report HIV-positive, did not test with CHiPs, and did not report an HIV-negative test result in the previous 3 months).
Among those whose HIV status was unknown to CHiPs, we assumed that HIV prevalence was the same as among those who tested for HIV. We then calculated: 2) the proportion who were on ART by the end of the study, among those who knew their HIVpositive status, as the total who self-reported they were on ART at the last CHiP visit made during the study, divided by the number who were known by the CHiPs to be HIV-positive and who remained resident in the same zone of the community according to the last information collected during the study.
We extrapolated to the total population by assuming that HIV prevalence was the same in nonparticipants and participants, and that knowledge of HIV-positive status and ART uptake among nonparticipants was the same as among participants immediately before the third annual round. 
Figure S4 -Screening and enrollment in PC0
Legend: Prior to the study, a complete census of all households (HH) in the area defined as the study community was conducted to provide the sampling frame for the population cohort. Households were selected at random for participation, and researchers visited each household to obtain consent to enumerate all household members and select at random an age-eligible member. The selected member was then approached for full eligibility assessment Overall rates are geometric means of individual community rates Adjusted for age and sex, 3 The number of HIV-positive men in age 18-24 was small in several communities, and some had zero with viral suppression, so log prevalence ratios were not defined and geometric means could not be computed 
